Welcome to the e-CCO Library Archive!

search
                             
search by: 
Filter:
P218. Evaluation of the burden of the disease in patients with Crohn's disease and complex perianal fistula
P218. Inflammatory bowel disease and pregnancy; our clinical experience
Authors:

A. Tezel1, G. Can1, G. Dökmeci1, A. Üstündag1, H.C. Ümit1, A.R. Soylu1, 1Trakya University Hospital, Gastroenterology Department, Edirne, Turkey

P218

Vitamin D status in IBD patients: a comparison of three different assays

Authors:

A. Krajcovicova*, T. Hlavaty, Z. Leskova, J. Payer

Faculty of Medicine Comenius Univeristy and University Hospital Bratislava , 5th Department of Internal Medicine , Bratislava, Slovakia

P219.

Faecal calprotectin is an accurate predictor of endoscopic and histological disease activity in IBD

Authors:

G. Chung-Faye, A. Rahman, K. Sandhu, B. Hayee, J. Tumova, R. Sherwood, King's College Hospital NHS Foundation Trust, Gastroenterology, London, United Kingdom

P219. Effect of mesenchymal stem cells to the level of adhesion molecules in patients with inflammatory bowel disease
P219. Inflammatory bowel disease in clinical practise: findings from a tertiary care center in Turkey
Authors:

S. Hulagu1, G. Sirin1, O. Sentürk1, A. Celebi1, 1Kocaeli University, Gastroenterology, Kocaeli, Turkey

P219. Solid organ transplantation and inflammatory bowel disease (IBD)
P219

The relevance of ileitis as diagnosed by capsule endoscopy: A comparison with double balloon enteroscopy

Authors:

B. Hall*, G. Holleran, D. Brennan, D. McNamara

Adelaide and Meath Hospital, Gastroenterology, Dublin, Ireland

P220.

Faecal calprotectin and ileal Crohn's disease: correlation with a small bowel MRI score for disease activity

Authors:

F. Fascì-Spurio1,2, N.A. Kennedy1,3, L. Wong4, P. MacLean4, J. Satsangi1,3, S. Glancy4, C.W. Lees1,3, 1Western General Hospital, Gastrointestinal Unit, Edinburgh, United Kingdom, 2Sapienza University, Gastroenterology Unit, Rome, Italy, 3University of Edinburgh, Gastrointestinal Unit, Centre for Genomic and Experimental Medicine, Edinburgh, United Kingdom, 4Western General Hospital, Department of Radiology, Edinburgh, United Kingdom

P220. Incidental diagnosis of inflammatory bowel disease in a British bowel cancer screening cohort: a multi-centre study
Authors:

R.O. Butcher1, S.J. Mehta2, O.F. Ahmad2, C.A. Boyd1, R. Anand2, J. Stein2, A.M. Abbasi1, R. George1, R.C. Prudham1, R. Vega2, S. McCartney2, S.L. Bloom2, J.K. Limdi1, 1Pennine Acute Hospitals NHS Trust, Gastroenterology, Manchester, United Kingdom, 2University College London Hospital, Gastroenterology, London, United Kingdom

P220. Induction of psoriasis with anti-TNF agents in patients with inflammatory bowel disease: A report of 19 cases
P220. Recombinant human erythropoietin in patients with inflammatory bowel disease and refractory anaemia: A 15-year single centre experience
P220

Diagnostic challenges in inflammatory bowel disease: fully automated immunoassay profiling of fecal biomarkers

Authors:

A. Kraemer1, M. Richter-Fecken*1, S. Hejc2, S. Jansen-Skoupy2

1ORGENTEC Diagnostika, R&D, Mainz, Germany, 2Kaiser-Franz-Josef-Hospital, Institute of Laboratory Diagnostics, Vienna, Austria

P221.

Faecal calprotectin concentrations in Crohn's patients with ileal disease location: correlations with disease activity as seen by MRI enterography

Authors:

F. Fascì-Spurio1, A. Chiappini1, V. Buonocore2, S. Cannizzaro1, Z. Maddalena1, F. Maccioni2, P. Vernia1, 1Sapienza University, Gastroenterology Unit, Policlinico Umberto I, Rome, Italy, 2Sapienza University, Radiology Department, Policlinico Umberto I, Rome, Italy

P221. Anxiety and psychological stress in acute severe ulcerative colitis: Prevalence and effect on outcome
P221. Incidence and risk factors for low urinary tract infections in patients with inflammatory bowel disease
Authors:

I. Gîrleanu1, A. Trifan1, A.-M. Singeap1, C. Cojocariu1, S. Chiriac1, C. Stanciu1, 1University of Medicine and Pharmacy Gr. T. Popa, Gastroenterology, Iasi, Romania

P221. Lacrimal function in patients with irritable bowel syndrome and inflammatory bowel disease
P221

Evolution of serological markers and their predictive value before and after right hemicolectomy with ileocolonic anastomosis in patients with Crohn's disease

Authors:

M. Noben*1, A. de Buck van Overstraeten2, S. Lockton3, B. Verstockt1, G. De Hertogh4, F. Princen3, A. Wolthuis2, G. Van Assche1, S. Vermeire1, S. Singh3, A. D'Hoore2, M. Ferrante1

1University Hospitals Leuven, Department of Gastroenterology, Leuven, Belgium, 2University Hospitals Leuven, Department of Abdominal Surgery, Leuven, Belgium, 3Prometheus Laboratories, Department of Research and Development, San Diego, United States, 4University Hospitals Leuven, Department of Pathology, Leuven, Belgium

P222.

Fecal calprotectin as a marker of severity of mucosal involvement in children with inflammatory bowel disease

Authors:

J. Dolinsek1, P. Riznik2, L. Sabath2, D. Micetic-Turk2, 1University Medical Centre, Gastroenterology Unit, Department of Paediatrics, Maribor, Slovenia, 2Medical Faculty, University of Maribor, Department of Paediatrics, Maribor, Slovenia

P222. Efficacy of different therapeutic options for spontaneous intraabdominal abscesses in Crohn's disease